|
1
|
Pourhoseingholi MA, Ashtari S, Hajizadeh
N, Fazeli Z and Zali MR: Systematic review of pancreatic cancer
epidemiology in Asia-Pacific Region: Major patterns in GLOBACON
2012. Gastroenterol Hepatol Bed Bench. 10:245–257. 2017.PubMed/NCBI
|
|
2
|
Kamisawa T, Wood LD, Itoi T and Takaori K:
Pancreatic cancer. Lancet. 388:73–85. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lin HL, Kuo LC, Chen CW, Lin YK and Lee
WC: Pancreatic tail cancer with sole manifestation of left flank
pain: A very rare presentation. Kaohsiung J Med Sci. 24:324–327.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
National Cancer Institute: Surveillance,
epidemiology, and end results program. Cancer stat facts, .
Pancreatic cancer. https://seer.cancer.gov/statfacts/html/pancreas.htmlJune
29–2018
|
|
5
|
Dhir V and Mohandas KM: Epidemiology of
digestive tract cancers in India IV. Gall bladder and pancreas.
Indian J Gastroenterol. 18:24–28. 1999.
|
|
6
|
Al-Shehri A, Silverman S and King KM:
Squamous cell carcinoma of the pancreas. Curr Oncol. 15:293–297.
2008.PubMed/NCBI
|
|
7
|
Schultheis AM, Nguyen GP, Ortmann M, Kruis
W, Büttner R, Schildhaus HU and Markiefka B: Squamous cell
carcinoma of the pancreas in a patient with germline BRCA2
mutation-response to neoadjuvant radiochemotherapy. Case Rep Oncol
Med. 2014:8605322014.PubMed/NCBI
|
|
8
|
Makarova-Rusher OV, Ulahannan S, Greten TF
and Duffy A: Pancreatic squamous cell carcinoma: A population-based
study of epidemiology, clinicopathologic characteristics and
outcomes. Pancreas. 45:1432–1437. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kodavatiganti R, Campbell F, Hashmi A and
Gollins SW: Primary squamous cell carcinoma of the pancreas: A case
report and review of the literature. J Med Case Reports. 6:295.
2012. View Article : Google Scholar
|
|
10
|
Mehta M, Sinha J, Ogawa M, Ganguly A,
Xiang D and Poddar N: Unusual Case of Squamous Cell Carcinoma of
Pancreas with Review of Literature. J Gastrointest Cancer.
46:426–429. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
NCCN Clinical Practice Guidelines in
Oncology. Pancreatic Adenocarcinoma. V1:2016, https://www.nccn.org/professionals/physician_gls/pdf/pancreatic.pdfJune
30–2018
|
|
12
|
Belli C, Cereda S and Reni M: Role of
taxanes in pancreatic cancer. World J Gastroenterol. 18:4457–4465.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
American Cancer Society: Signs and
symptoms of pancreatic cancer. https://www.cancer.org/cancer/pancreatic-cancer/detection-diagnosis-staging/signs-and-symptoms.html28–February.
2018
|
|
14
|
Artinyan A, Soriano PA, Prendergast C, Low
T, Ellenhorn JD and Kim J: The anatomic location of pancreatic
cancer is a prognostic factor for survival. HPB (Oxford).
10:371–376. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gunjan D, Rana S, Chhabra P, Parghane R,
Kumar R, Dhalaria L, Mittal B and Bhasin D: Primary squamous cell
carcinoma of pancreas mimicking walled-off pancreatic necrosis. J
Dig Endosc. 7:17–19. 2016. View Article : Google Scholar
|
|
16
|
Ben Kridis W, Khanfir A, Toumi N, Ben Amar
M, Boudawara T and Frikha M: Primary squamous cell carcinoma of the
pancreas: A report of two cases and review of the literature.
Intern Med. 54:1357–1359. 2015. View Article : Google Scholar
|
|
17
|
Terada T: Adenosquamous Carcinoma and Pure
Squamous Cell Carcinoma of the Pancreas: Report of two Cases. Case
Rep Gastroenterol. 4:369–373. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tempero MA: Multidisciplinary management
of pancreatic cancer. J Natl Compr Canc Netw. 13 Suppl 5:700–702.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chakraborty S and Singh S: Surgical
resection improves survival in pancreatic cancer patients without
vascular invasion- a population based study. Ann Gastroenterol.
26:346–352. 2013.PubMed/NCBI
|
|
20
|
Hackert T, Sachsenmaier M, Hinz U,
Schneider L, Michalski CW, Springfeld C, Strobel O, Jäger D, Ulrich
A and Büchler MW: Locally advanced pancreatic cancer: Neoadjuvant
therapy with folfirinox results in resectability in 60% of the
patients. Ann Surg. 264:457–463. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bideau K, Metges JP, Bayle S, André M,
Robaszkiewicz M, Lagarde N and Labat JP: Treatment of squamous cell
carcinoma of the pancreas with gemcitabine. Gastroenterol Clin
Biol. 30:1217–1220. 2006.(In French). View Article : Google Scholar : PubMed/NCBI
|
|
22
|
De Souza AL and Saif MW: Squamous cell
carcinoma of the pancreas. JOP. 15:630–631. 2014.PubMed/NCBI
|
|
23
|
Von Hoff DD, Ervin T, Arena FP, Chiorean
EG, Infante J, Moore M, Seay T, Tjulandin SA, Ma WW, Saleh MN, et
al: Increased survival in pancreatic cancer with nab-paclitaxel
plus gemcitabine. N Engl J Med. 369:1691–1703. 2013. View Article : Google Scholar
|
|
24
|
Von Hoff DD, Ramanathan RK, Borad MJ,
Laheru DA, Smith LS, Wood TE, Korn RL, Desai N, Trieu V, Iglesias
JL, et al: Gemcitabine plus nab-paclitaxel is an active regimen in
patients with advanced pancreatic cancer: A phase I/II trial. J
Clin Oncol. 29:4548–4554. 2011. View Article : Google Scholar
|
|
25
|
Kataoka K, Matsubara H, Urano F, Okamura S
and Maeda M: Nab-paclitaxel+gemcitabine therapy for adenosquamous
carcinoma of the pancreas: An autopsy case. Nihon Shokakibyo Gakkai
Zasshi. 113:1777–1784. 2016.(In Japanese). PubMed/NCBI
|
|
26
|
Brijbassie A, Stelow E and Shami VM:
Squamous cell carcinoma of the pancreas: A case report and review
of literature. Gastroenterol Res. 7:102–104. 2014.
|
|
27
|
Serafini F, Rosemurgy AS II and Carey LC:
Squamous cell carcinoma of the pancreas. Am J Gastroenterol.
91:2621–2622. 1996.PubMed/NCBI
|
|
28
|
Brown HA, Dotto J, Robert M and Salem RR:
Squamous cell carcinoma of the pancreas. J Clin Gastroenterol.
39:915–919. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ntanasis-Stathopoulos I, Tsilimigras DI,
Georgiadou D, Kanavidis P, Riccioni O, Salla C, Psaltopoulou T and
Sergentanis TN: Squamous cell carcinoma of the pancreas: A
systematic review and pooled survival analysis. Eur J Cancer.
79:193–204. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ahmad A, Sheikh S, Ali SM, Paithankar M,
Mehta A and Nagarkar R: Nanosomal paclitaxel lipid suspension
demonstrates higher response rates compared to paclitaxel in
patients with metastatic breast cancer. J Cancer Sci Ther.
07:116–120. 2015.
|
|
31
|
Gelderblom H, Verweij J, Nooter K and
Sparreboom A: Cremophor EL: The drawbacks and advantages of vehicle
selection for drug formulation. Eur J Cancer. 37:1590–1598. 2001.
View Article : Google Scholar : PubMed/NCBI
|
